Back to top
more

Phreesia (PHR)

(Delayed Data from NYSE)

$20.61 USD

20.61
502,316

+0.15 (0.73%)

Updated Apr 26, 2024 04:00 PM ET

After-Market: $20.58 -0.03 (-0.15%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value A Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 34% (85 out of 252)

Industry: Medical Info Systems

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for PHR

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for Phreesia, Inc falls in the month of January.

All items in Millions except Per Share data.

1/31/2024 1/31/2023 1/31/2022 1/31/2021 1/31/2020
Assets          
Cash & Equivalents 88 177 314 219 90
Receivables 65 51 40 29 22
Notes Receivable 0 0 0 0 0
Inventories 0 0 0 0 0
Other Current Assets 43 34 32 24 19
Total Current Assets 196 262 386 272 132
Net Property & Equipment 63 57 52 37 23
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 1 2 3 2 2
Intangibles 107 45 46 11 1
Deposits & Other Assets 3 3 4 2 0
Total Assets 370 370 494 327 159
Liabilities & Shareholders Equity 1/31/2024 1/31/2023 1/31/2022 1/31/2021 1/31/2020
Notes Payable 0 0 0 0 0
Accounts Payable 8 11 5 4 6
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 6 5 6 5 2
Accrued Expenses 37 22 20 18 9
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 58 40 36 26 18
Total Current Liabilities 110 79 68 55 35
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 0 0
Convertible Debt 0 0 0 0 0
Long-Term Debt 0 0 0 6 19
Non-Current Capital Leases 5 3 7 0 2
Other Non-Current Liabilities 3 0 0 0 0
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 119 82 77 63 57
Shareholders Equity 1/31/2024 1/31/2023 1/31/2022 1/31/2021 1/31/2020
Preferred Stock 0 0 0 0 0
Common Stock (Par) 1 1 1 0 0
Capital Surplus 1,039 927 861 580 386
Retained Earnings -743 -606 -430 -312 -284
Other Equity 0 0 0 0 0
Treasury Stock 46 34 14 5 0
Total Shareholder's Equity 251 288 417 263 102
Total Liabilities & Shareholder's Equity 370 370 494 327 159
Total Common Equity 251 288 417 263 102
Shares Outstanding 55.60 52.70 51.20 44.10 35.80
Book Value Per Share 4.52 5.46 8.15 5.97 2.85

Fiscal Year End for Phreesia, Inc falls in the month of January.

All items in Millions except Per Share data.

1/31/2024 10/31/2023 7/31/2023 4/30/2023 1/31/2023
Assets          
Cash & Equivalents 88 103 128 150 177
Receivables 65 57 54 53 51
Notes Receivable 0 0 0 0 0
Inventories 0 0 0 0 0
Other Current Assets 43 38 38 37 34
Total Current Assets 196 199 219 240 262
Net Property & Equipment 63 64 64 64 57
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 1 1 1 2 2
Intangibles 107 108 54 45 45
Deposits & Other Assets 3 2 2 3 3
Total Assets 370 375 340 354 370
Liabilities & Shareholders Equity 1/31/2024 10/31/2023 7/31/2023 4/30/2023 1/31/2023
Notes Payable 0 0 0 0 0
Accounts Payable 8 11 8 8 11
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 6 7 7 7 5
Accrued Expenses 37 28 28 23 22
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 58 52 42 44 40
Total Current Liabilities 110 98 85 83 79
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 0 0
Convertible Debt 0 0 0 0 0
Long-Term Debt 0 0 0 0 0
Non-Current Capital Leases 5 7 8 7 3
Other Non-Current Liabilities 3 0 0 0
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 119 110 93 90 82
Shareholders Equity 1/31/2024 10/31/2023 7/31/2023 4/30/2023 1/31/2023
Preferred Stock 0 0 0 0 0
Common Stock (Par) 1 1 1 1 1
Capital Surplus 1,039 1,022 971 947 927
Retained Earnings -743 -712 -680 -644 -606
Other Equity 0 0 0 0 0
Treasury Stock 46 46 44 41 34
Total Shareholder's Equity 251 265 247 264 288
Total Liabilities & Shareholder's Equity 370 375 340 354 370
Total Common Equity 251 265 247 264 288
Shares Outstanding 55.60 55.20 53.60 53.60 52.70
Book Value Per Share 4.52 4.79 4.61 4.92 5.46